- Home
- ANTE vs PLRZ Comparison
ANTE vs PLRZ Comparison
Compare ANTE & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- PLRZ
- Stock Information
- Founded
- ANTE 2005
- PLRZ 2005
- Country
- ANTE China
- PLRZ Israel
- Employees
- ANTE N/A
- PLRZ N/A
- Industry
- ANTE Advertising
- PLRZ
- Sector
- ANTE Consumer Discretionary
- PLRZ
- Exchange
- ANTE Nasdaq
- PLRZ NYSE
- Market Cap
- ANTE 6.7M
- PLRZ 5.9M
- IPO Year
- ANTE N/A
- PLRZ 2024
- Fundamental
- Price
- ANTE $0.54
- PLRZ $1.04
- Analyst Decision
- ANTE
- PLRZ
- Analyst Count
- ANTE 0
- PLRZ 0
- Target Price
- ANTE N/A
- PLRZ N/A
- AVG Volume (30 Days)
- ANTE 117.9K
- PLRZ 136.1K
- Earning Date
- ANTE 09-30-2024
- PLRZ 02-15-2025
- Dividend Yield
- ANTE N/A
- PLRZ N/A
- EPS Growth
- ANTE N/A
- PLRZ N/A
- EPS
- ANTE 2.64
- PLRZ N/A
- Revenue
- ANTE $500,000.00
- PLRZ N/A
- Revenue This Year
- ANTE N/A
- PLRZ N/A
- Revenue Next Year
- ANTE N/A
- PLRZ N/A
- P/E Ratio
- ANTE $0.20
- PLRZ N/A
- Revenue Growth
- ANTE N/A
- PLRZ N/A
- 52 Week Low
- ANTE $0.26
- PLRZ $0.77
- 52 Week High
- ANTE $2.90
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- ANTE 62.42
- PLRZ N/A
- Support Level
- ANTE $0.42
- PLRZ N/A
- Resistance Level
- ANTE $0.58
- PLRZ N/A
- Average True Range (ATR)
- ANTE 0.03
- PLRZ 0.00
- MACD
- ANTE 0.01
- PLRZ 0.00
- Stochastic Oscillator
- ANTE 75.00
- PLRZ 0.00
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.